Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Dexamethasone at Night for PONV in Laparoscopic Cholecystectomy
NCT06288035Phase 3Recruiting
- Sponsor
- Mansoura University
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Mansoura University. Primary endpoint: Postoperative nausea and vomiting. Started Mar 2024; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06288035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06288035.